The future of biomarkers in toxicology is promising, with ongoing research focusing on the development of more advanced and precise biomarkers. Emerging technologies such as omics (genomics, proteomics, metabolomics) are providing new insights into biomarker discovery. High-throughput screening and computational models are also being used to predict biomarker responses, potentially leading to personalized approaches in toxicology.
